The Role of Endoscopic Ultrasound in Evaluating Rectal Cancer
Author Information
Author(s): Siddiqui Ali A, Fayiga Yomi, Huerta Sergio
Primary Institution: VA North Texas Health Care System and University of Texas Southwestern Medical School
Hypothesis
Is endoscopic ultrasound (EUS) an effective method for staging rectal cancer compared to other imaging techniques?
Conclusion
Endoscopic ultrasound is an accurate modality for clinical staging of rectal cancer and can guide neoadjuvant treatment.
Supporting Evidence
- EUS accuracy for T staging ranges from 80-95%, compared to CT's 65-75%.
- EUS can potentially upstage patients, making them eligible for neoadjuvant treatment.
- EUS guided FNA may be beneficial for early T stage disease with suspicious lymph nodes.
- Routine use of EUS can change treatment plans for nearly one third of patients.
- EUS has a 100% positive predictive value for identifying T3/T4 disease.
Takeaway
Doctors use a special ultrasound to look inside the rectum to see how deep the cancer is and if it has spread, which helps them decide the best treatment.
Methodology
The study reviews the accuracy of endoscopic ultrasound (EUS) for staging rectal cancer and compares it with CT and MRI.
Potential Biases
Operator experience can influence the accuracy of EUS staging.
Limitations
EUS may under-stage T3 tumors and has reduced accuracy after radiation therapy.
Participant Demographics
Patients diagnosed with rectal cancer, specifically those with early T stage disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website